Wire · regulatory
DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 13 August 2026 · Fusion42 review
Diagnos Inc. received Medical Device Marketing Authorization from the Saudi Food and Drug Authority for its CARA System, an AI-assisted retinal image analysis device detecting Diabetic Retinopathy and Age-related Macular Degeneration. This approval opens access to a large market of over 5 million adults in Saudi Arabia needing regular screening for these conditions.
This Wire brief sits within Fusion42's coverage of Digital Health, and 3 sources have reported it.
◆ ◆ The Wire takeaway
You gain a new market unlocked by Saudi FDA approval of AI retinal screening tech; start building local healthcare partnerships now to reach millions needing diabetic eye care.
◆ Coverage
3 sources · 13 Aug 2026
◆ Related on Wire
◆ Topics